Literature DB >> 23002939

Stroke rehabilitation using noninvasive cortical stimulation: motor deficit.

Samar S Ayache1, Wassim H Farhat, Hela G Zouari, Hassan Hosseini, Veit Mylius, Jean-Pascal Lefaucheur.   

Abstract

Noninvasive cortical stimulation (NICS) has been used during the acute, postacute and chronic poststroke phases to improve motor recovery in stroke patients having upper- and/or lower-limb paresis. This paper reviews the rationale for using the different NICS modalities to promote motor stroke rehabilitation. The changes in cortical excitability after stroke and the possible mechanisms of action of cortical stimulation in this context are outlined. A number of open and placebo-controlled trials have investigated the clinical effect of repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) of the primary motor cortex in patients with motor stroke. These studies attempted to improve motor performance by increasing cortical excitability in the stroke-affected hemisphere (via high-frequency rTMS or anodal tDCS) or by decreasing cortical excitability in the contralateral hemisphere (via low-frequency rTMS or cathodal tDCS). The goal of these studies was to reduce the inhibition exerted by the unaffected hemisphere on the affected hemisphere and to then restore a normal balance of interhemispheric inhibition. All these NICS techniques administered alone or in combination with various methods of neurorehabilitation were found to be safe and equally effective at the short term on various aspects of poststroke motor abilities. However, the long-term effect of NICS on motor stroke needs to be further evaluated before considering the use of such a technique in the daily routine management of stroke.

Entities:  

Mesh:

Year:  2012        PMID: 23002939     DOI: 10.1586/ern.12.83

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  8 in total

1.  Double-Blind Sham-Controlled Crossover Trial of Repetitive Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome.

Authors:  Yoon-Hee Cha; Choi Deblieck; Allan D Wu
Journal:  Otol Neurotol       Date:  2016-07       Impact factor: 2.311

2.  Individualized treatment with transcranial direct current stimulation in patients with chronic non-fluent aphasia due to stroke.

Authors:  Priyanka P Shah-Basak; Catherine Norise; Gabriella Garcia; Jose Torres; Olufunsho Faseyitan; Roy H Hamilton
Journal:  Front Hum Neurosci       Date:  2015-04-21       Impact factor: 3.169

Review 3.  The Motion of Body Center of Mass During Walking: A Review Oriented to Clinical Applications.

Authors:  Luigi Tesio; Viviana Rota
Journal:  Front Neurol       Date:  2019-09-20       Impact factor: 4.003

4.  Genetic Algorithm for TMS Coil Position Optimization in Stroke Treatment.

Authors:  Shujie Lu; Haoyu Jiang; Chengwei Li; Baoyu Hong; Pu Zhang; Wenli Liu
Journal:  Front Public Health       Date:  2022-03-11

5.  The cerebellum is linked to theory of mind alterations in autism. A direct clinical and MRI comparison between individuals with autism and cerebellar neurodegenerative pathologies.

Authors:  Silvia Clausi; Giusy Olivito; Libera Siciliano; Michela Lupo; Fiorenzo Laghi; Roberto Baiocco; Maria Leggio
Journal:  Autism Res       Date:  2021-08-10       Impact factor: 4.633

6.  Do movement-related beta oscillations change after stroke?

Authors:  Holly E Rossiter; Marie-Hélène Boudrias; Nick S Ward
Journal:  J Neurophysiol       Date:  2014-07-30       Impact factor: 2.714

7.  Effects of Excitatory Repetitive Transcranial Magnetic Stimulation of the P3 Point in Chronic Stroke Patients-Case Reports.

Authors:  Ronaldo Luis da Silva; Angela Maria Costa de Souza; Francielly Ferreira Santos; Sueli Toshie Inoue; Johanne Higgins; Victor Frak
Journal:  Brain Sci       Date:  2018-04-28

Review 8.  A New Framework to Interpret Individual Inter-Hemispheric Compensatory Communication after Stroke.

Authors:  Arianna Brancaccio; Davide Tabarelli; Paolo Belardinelli
Journal:  J Pers Med       Date:  2022-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.